Detalhe da pesquisa
1.
Liquid Biopsy Snapshots of Key Phosphoproteomic Pathways in Lung Cancer Patients for Diagnosis and Therapy Monitoring.
Anal Chem
; 95(22): 8522-8532, 2023 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37224231
2.
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
N Engl J Med
; 378(15): 1408-1418, 2018 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29420164
3.
Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 19(10): 1404-1416, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213449
4.
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 373(19): 1814-23, 2015 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26406150
5.
Enzalutamide in metastatic prostate cancer before chemotherapy.
N Engl J Med
; 371(5): 424-33, 2014 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-24881730
6.
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial.
Lancet Oncol
; 17(7): 917-927, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27279544
7.
Abiraterone in metastatic prostate cancer without previous chemotherapy.
N Engl J Med
; 368(2): 138-48, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23228172
8.
Toward Precision Medicine: A Cancer Molecular Subtyping Nano-Strategy for RNA Biomarkers in Tumor and Urine.
Small
; 12(45): 6233-6242, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717152
9.
Increased survival with enzalutamide in prostate cancer after chemotherapy.
N Engl J Med
; 367(13): 1187-97, 2012 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22894553
10.
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial.
Lancet Oncol
; 15(11): 1263-8, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25242048
11.
Abiraterone and increased survival in metastatic prostate cancer.
N Engl J Med
; 364(21): 1995-2005, 2011 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21612468
12.
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial.
Lancet Oncol
; 14(12): 1193-9, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24075621
13.
A Mesoporous Gold Sensor Unveils Phospho PD-L1 in Extracellular Vesicles as a Proxy for PD-L1 Expression in Lung Cancer Tissue.
ACS Sens
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38836608
14.
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study.
Lancet Oncol
; 13(10): 983-92, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22995653
15.
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial.
Lancet Oncol
; 13(12): 1210-7, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23142059
16.
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer.
Breast Cancer Res Treat
; 135(1): 241-52, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22872523
17.
Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel.
Invest New Drugs
; 30(3): 1065-73, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21327495
18.
Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?
Cancers (Basel)
; 14(3)2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158916
19.
Harnessing gene fusion-derived neoantigens for 'cold' breast and prostate tumor immunotherapy.
Immunotherapy
; 14(14): 1165-1179, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36043380
20.
A digital single-molecule nanopillar SERS platform for predicting and monitoring immune toxicities in immunotherapy.
Nat Commun
; 12(1): 1087, 2021 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597530